Editorial: risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease-the longer the less?

被引：0
|
作者：
Goren, Idan [1 ,2 ]
Yanai, Henit [1 ,2 ]
机构：
[1] Rabin Med Ctr, Div Gastroenterol, IBD Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 02期
关键词：
INFLIXIMAB; DRUG;
D O I：
10.1111/apt.16648
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：244 / 245
页数：2
相关论文
共 50 条
  • [31] Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
    Dai, Cong
    Jiang, Min
    Huang, Yu-hong
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E156 - E156
  • [32] Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
    Santella, Christina
    Bitton, Alain
    Filliter, Christopher
    Bessissow, Talat
    Vutcovici, Maria
    Lakatos, Peter L.
    Brassard, Paul
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 176 - 182
  • [33] Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
    Eun, Chang Soo
    [J]. GUT AND LIVER, 2017, 11 (01) : 3 - 4
  • [34] Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
    Guerra, Ivan
    Algaba, Alicia
    Lazaro Perez-Calle, Jose
    Chaparro, Maria
    Marin-Jimenez, Ignacio
    Garcia-Castellanos, Raquel
    Gonzalez-Lama, Yago
    Lopez-Sanroman, Antonio
    Mancenido, Noemi
    Martinez-Montiel, Pilar
    Quintanilla, Elvira
    Taxonera, Carlos
    Villafruela, Monica
    Romero-Mate, Alberto
    Lopez-Serrano, Pilar
    Gisbert, Javier P.
    Bermejo, Fernando
    [J]. JOURNAL OF CROHNS & COLITIS, 2012, 6 (05): : 518 - 523
  • [35] Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma-challenges in management
    Lee, Jungmin
    Clarke, Kofi
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (12) : 1595 - 1602
  • [36] Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Torres, Paola
    Canete, Fiorella
    Nunez, Laura
    Aguilar, Ariadna
    Mesonero, Francisco
    Calafat, Margalida
    Fernandez, Cristina
    Teniente, Aina
    Manosa, Miriam
    Lopez-Sanroman, Antonio
    Domenech, Eugeni
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (07) : 2036 - 2043
  • [37] Spacing the administration interval of anti-TNF agents: a valid strategy for patients with inflammatory bowel disease?
    Torres, P.
    Nunez, L.
    Aguilar, A.
    Manosa, M.
    Mesonero, F.
    Canete, F.
    Calafat, M.
    Fernandez, C.
    Cabre, E.
    Lopez-Sanroman, A.
    Domenech, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S359 - S360
  • [38] Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Paola Torres
    Fiorella Cañete
    Laura Núñez
    Ariadna Aguilar
    Francisco Mesonero
    Margalida Calafat
    Cristina Fernández
    Aïna Teniente
    Míriam Mañosa
    Antonio López-Sanromán
    Eugeni Domènech
    [J]. Digestive Diseases and Sciences, 2020, 65 : 2036 - 2043
  • [39] Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease
    Wang, Ming-Hsi
    Friton, Jessica J.
    Raffals, Laura E.
    Leighton, Jonathan A.
    Pasha, Shabana F.
    Picco, Michael F.
    Cushing, Kelly C.
    Monroe, Kelly
    Nix, Billy D.
    Newberry, Rodney D.
    Faubion, William A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (08): : 1036 - 1043
  • [40] Efficacy of combination therapy with methotrexate and anti-TNF agents in inflammatory bowel disease
    Park, Jihye
    Cheon, Jae Hee
    Park, Jae Jun
    Park, Yehyun
    Park, Soo Jung
    Kim, Tae Il
    Kim, Won Ho
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 462 - 462
12345